Chromosomal microarray (CMA) is recommended as the first-tier test in evaluation of individuals with neurodevelopmental disability and congenital anomalies. CMA may not detect balanced cytogenomic ...
Chromosomal copy-number variations (CNVs) are a class of genetic variants highly implicated in the aetiology of neurodevelopmental disorders, including intellectual disabilities (ID), schizophrenia ...
Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...
Please provide your email address to receive an email when new articles are posted on . Chromosomal microarray analysis should be considered as a first-tier genetic diagnostic test for autism spectrum ...
Thermo Fisher Scientific Inc., announced that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic ...
Applied Biosystems™ CytoScan™ Dx and Chromosome Analysis Suite (ChAS) Dx software provide complete solution to support cytogenetic testing CARLSBAD, Calif.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results